Calhoun Lesley Ann

CIK 00017308663 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001730866

Recent Transactions

50 trades

Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-07-16+40,185→ 40,185 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-06-05+6,250→ 12,500 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2025-06-05+37,500→ 37,500 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2025-02-28+47,271→ 47,271 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-09-04+10,880→ 10,880 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2024-06-05+37,500→ 37,500 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-06-05$7.21/sh+5,000→ 6,250 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-06-05+6,250→ 11,250 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-03-01+308,940→ 308,940 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+18,750→ 18,750 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+74,998→ 74,998 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+51,833→ 51,833 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−26,250→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−105,000→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−176,237→ 0 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-09-08+48,000→ 48,000 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2023-06-06+5,000→ 5,000 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2023-06-06+30,000→ 30,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-03-15+78,750→ 78,750 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-07-07+52,500→ 52,500 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2022-06-08+40,000→ 40,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+26,250→ 26,250 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-02-04+105,000→ 105,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2020-12-01+176,237→ 176,237 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-26−2,700→ 900 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-05-26$70.10/sh−2,700→ 154 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-05-26$29.75/sh+2,700→ 2,854 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-05-18$22.00/sh+23,330→ 23,484 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-05-18$74.67/sh−23,330→ 154 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-18−23,330→ 1,875 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-05-12$78.38/sh−2,992→ 154 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-05-11$77.05/sh−381→ 3,146 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01+300→ 3,631 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-03-01−300→ 600 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01$63.96/sh−104→ 3,527 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03+14,610→ 14,610 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-03+9,160→ 9,160 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-01+3,063→ 4,485 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-01−2,313→ 13,875 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-02-01$65.26/sh−1,154→ 3,331 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-01−750→ 3,000 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2020-01-31$36.68/sh+535→ 1,422 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2019-09-11$54.36/sh−2,765→ 887 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2019-09-01$45.98/sh−104→ 3,652 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2019-09-01+300→ 3,756 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-09-01−300→ 900 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-08-01−2,312→ 16,188 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2019-08-01$54.25/sh−1,060→ 3,456 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-08-01−750→ 3,750 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2019-08-01+3,062→ 4,516 total

Companies

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov